ciprofloxacin has been researched along with Travel Sickness in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Korea, typhoid fever is a rare disease due to improved living standards." | 1.62 | Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India. ( Chun, JH; Hwang, KJ; Jeong, HJ; Kim, CJ; Kim, J; Lee, H; Na, K; Park, AK; Park, J; Shin, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Park, AK | 2 |
| Shin, E | 2 |
| Kim, S | 1 |
| Park, J | 2 |
| Jeong, HJ | 2 |
| Chun, JH | 2 |
| Hwang, KJ | 2 |
| Kim, J | 2 |
| Amicizia, D | 1 |
| Micale, RT | 1 |
| Pennati, BM | 1 |
| Zangrillo, F | 1 |
| Iovine, M | 1 |
| Lecini, E | 1 |
| Marchini, F | 1 |
| Lai, PL | 1 |
| Panatto, D | 1 |
| Willerton, L | 1 |
| Lucidarme, J | 1 |
| Campbell, H | 1 |
| Caugant, DA | 1 |
| Claus, H | 1 |
| Jacobsson, S | 1 |
| Ladhani, SN | 1 |
| Mölling, P | 1 |
| Neri, A | 1 |
| Stefanelli, P | 1 |
| Taha, MK | 1 |
| Vogel, U | 1 |
| Borrow, R | 1 |
| Na, K | 1 |
| Lee, H | 1 |
| Kim, CJ | 1 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Haley, BJ | 1 |
| Kim, SW | 1 |
| Haendiges, J | 1 |
| Keller, E | 1 |
| Torpey, D | 1 |
| Kim, A | 1 |
| Crocker, K | 1 |
| Myers, RA | 1 |
| Van Kessel, JAS | 1 |
| Olszewski, AE | 1 |
| Karandikar, MV | 1 |
| Surana, NK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Study of Commercially Available Typhoid Point of Care Tests to Benchmark Current and Emerging Tools[NCT04673487] | 2,000 participants (Anticipated) | Observational | 2021-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ciprofloxacin and Travel Sickness
| Article | Year |
|---|---|
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; C | 2019 |
Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature.
Topics: Aeromonas; Breast Diseases; Child; Ciprofloxacin; Dominican Republic; Female; Folliculitis; Gram-Neg | 2017 |
5 other studies available for ciprofloxacin and Travel Sickness
| Article | Year |
|---|---|
Traveller-associated high-level ciprofloxacin-resistant Salmonella enterica Serovar Kentucky in the Republic of Korea.
Topics: Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Multilocus Sequence Typing; Phylogeny; | 2020 |
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex.
Topics: Ciprofloxacin; England; Europe; Germany; Humans; Italy; Meningococcal Infections; Neisseria meningit | 2020 |
Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Haplotypes; Humans; Indi | 2021 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland, USA (2011-2015).
Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; High-Throughput Nuc | 2019 |